Cargando…

Mechanisms of proton pump inhibitor‐induced hypomagnesemia

Proton pump inhibitors (PPIs) reliably suppress gastric acid secretion and are therefore the first‐line treatment for gastric acid‐related disorders. Hypomagnesemia (serum magnesium [Mg(2+)] <0.7 mmol/L) is a commonly reported side effect of PPIs. Clinical reports demonstrate that urinary Mg(2+)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gommers, Lisanne M. M., Hoenderop, Joost G. J., de Baaij, Jeroen H. F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539870/ https://www.ncbi.nlm.nih.gov/pubmed/35652564 http://dx.doi.org/10.1111/apha.13846

Ejemplares similares

Dietary Inulin Fibers Prevent Proton-Pump Inhibitor (PPI)-Induced Hypocalcemia in Mice
por: Hess, Mark W., et al.
Publicado: (2015)

Diabetes-induced hypomagnesemia is not modulated by metformin treatment in mice
por: Kurstjens, Steef, et al.
Publicado: (2019)

Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors
por: Janett, Simone, et al.
Publicado: (2015)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Is hypomagnesemia associated with using proton pump inhibitors?
por: Yi, Joo-Hark, et al.
Publicado: (2016)

Hypomagnesemia and Cardiovascular Risk in Type 2 Diabetes
por: Oost, Lynette J, et al.
Publicado: (2022)

Proton-pump inhibitor use amongst patients with severe hypomagnesemia
por: Seah, Sherry, et al.
Publicado: (2023)

Proton Pump Inhibitor-Induced Hypomagnesemia: A Rare, Potentially Fatal Complication
por: Pawlukiewicz, Alec J, et al.
Publicado: (2020)

Genetic causes of hypomagnesemia, a clinical overview
por: Viering, Daan H. H. M, et al.
Publicado: (2016)

Proton pump inhibitors and hypomagnesemia: A meta-analysis of observational studies
por: Srinutta, Thawin, et al.
Publicado: (2019)

Proton-pump Inhibitor-induced Severe Hypomagnesemia and Hypocalcemia are Clinically Masked by Thiazide Diuretic
por: Uehara, Atsuko, et al.
Publicado: (2019)

Mechanisms of ion transport regulation by HNF1β in the kidney: beyond transcriptional regulation of channels and transporters
por: Tholen, Lotte E., et al.
Publicado: (2022)

Proton Pump Inhibitors and Hospitalization with Hypomagnesemia: A Population-Based Case-Control Study
por: Zipursky, Jonathan, et al.
Publicado: (2014)

Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia
por: Boerlage, Thomas C. C., et al.
Publicado: (2016)

Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease
por: Hughes, John, et al.
Publicado: (2018)

CNNM2 Mutations Cause Impaired Brain Development and Seizures in Patients with Hypomagnesemia
por: Arjona, Francisco J., et al.
Publicado: (2014)

Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication
por: Semb, Synne, et al.
Publicado: (2017)

Correction to: Mechanisms of ion transport regulation by HNF1β in the kidney: beyond transcriptional regulation of channels and transporters
por: Tholen, Lotte E., et al.
Publicado: (2022)

The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia: A Systematic Review and Meta-Analysis
por: Park, Chan Hyuk, et al.
Publicado: (2014)

Does the use of proton pump inhibitors increase the risk of hypomagnesemia: An updated systematic review and meta-analysis
por: Liao, Shengtao, et al.
Publicado: (2019)

Hypomagnesemia Caused by Chronic Use of Over-the-Counter Proton Pump Inhibitor as a Possible Cause of Supraventricular Tachycardia
por: Ortega, Francisco J, et al.
Publicado: (2023)

The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia in a National Cohort of Veteran Patients with HIV
por: Sutton, S. Scott, et al.
Publicado: (2019)

Relationship between long-term use of proton pump inhibitor (PPI) and hypomagnesemia in patients with gastroesophageal reflux disease
por: Arj, Abbas, et al.
Publicado: (2022)

Magnesium to prevent kidney disease–associated vascular calcification: crystal clear?
por: ter Braake, Anique D, et al.
Publicado: (2020)

Regulation of magnesium balance: lessons learned from human genetic disease
por: de Baaij, Jeroen H. F., et al.
Publicado: (2012)

The association between hypomagnesemia and poor glycaemic control in type 1 diabetes is limited to insulin resistant individuals
por: Oost, Lynette J., et al.
Publicado: (2022)

Tacrolimus‐induced hypomagnesemia and hypercalciuria requires FKBP12 suggesting a role for calcineurin
por: Gratreak, Brittany D. K., et al.
Publicado: (2020)

Low extracellular magnesium does not impair glucose-stimulated insulin secretion
por: Gommers, Lisanne M. M., et al.
Publicado: (2019)

Butyrate reduces cellular magnesium absorption independently of metabolic regulation in Caco-2 human colon cells
por: Gommers, Lisanne M. M., et al.
Publicado: (2022)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Proton Pump Inhibitor and Tacrolimus Uses are Associated With Hypomagnesemia in Connective Tissue Disease: a Potential Link With Renal Dysfunction and Recurrent Infection
por: Hanaoka, Hironari, et al.
Publicado: (2021)

Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation
por: ter Braake, Anique D., et al.
Publicado: (2018)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

An overview of diagnosis and management of drug‐induced hypomagnesemia
por: Liamis, George, et al.
Publicado: (2021)

Magnesium increases insulin-dependent glucose uptake in adipocytes
por: Oost, Lynette J., et al.
Publicado: (2022)

Proton Pump Inhibitors in Pediatrics: Mechanism of Action, Pharmacokinetics, Pharmacogenetics, and Pharmacodynamics
por: Ward, Robert M., et al.
Publicado: (2013)

Proton Pump Inhibitors and Dementia: Physiopathological Mechanisms and Clinical Consequences
por: Ortiz-Guerrero, Gloria, et al.
Publicado: (2018)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

P2X6 Knockout Mice Exhibit Normal Electrolyte Homeostasis
por: de Baaij, Jeroen H. F., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ovovgdi4tdkbos6slt42hmv66p